QA: Cyclerion Therapeutics Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001755237_2020_Cyclerion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001755237, Cyclerion Therapeutics Inc.

  xvar xval
0 AssetsCurrent 101,197,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,613,000
3 remainder_Assets 73,668,000
4 LiabilitiesCurrent 18,249,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,404,000
9 ResearchAndDevelopmentExpense 95,140,000
10 remainder_Expenses 0
11 remainder_Revenues 4,507,000
12 remainder_NetIncome 2,029,000
13 remainder_ComprehensiveNetIncome -20,000
  yvar yval
0 Assets 186,478,000
1 Liabilities 18,249,000
2 Expenses 129,544,000
3 Revenues 4,507,000
4 StockholdersEquity 168,229,000
5 NetIncome -123,008,000
6 ComprehensiveNetIncome -123,018,000
7 BaseVar 170,413,500
8 EconomicCapitalRatio 1.62

Edgar->Model Mapping

Feature Distribution

Change over Time